NSE ScannerComparison · NSE · data 2026-11-01
Biofil Chemicals & Pharmaceuticals Ltd. vs Onyx Biotec Ltd.
In plain words
Size: Onyx Biotec Ltd. is about 1.4 times the market value of Biofil Chemicals & Pharmaceuticals Ltd..
Return on equity: Biofil Chemicals & Pharmaceuticals Ltd. 13.8% vs Onyx Biotec Ltd. -0.4%.
Debt to equity: Onyx Biotec Ltd. 0.27 vs Biofil Chemicals & Pharmaceuticals Ltd. 0.14.
Differences in the numbers, not a recommendation of either stock.
Side by side
| BIOFILCHEM | ONYX | |
|---|---|---|
| Price | ₹28.68 | ₹36 |
| Market cap | ₹47 cr | ₹65 cr |
| P/E | 96.4 | — |
| P/B | — | — |
| ROE | 13.8% | -0.4% |
| ROCE | 1.8% | 0.5% |
| Debt / equity | 0.14 | 0.27 |
| Operating margin | 1.5% | 0.5% |
| Dividend yield | 0.00% | 0.00% |
| Sales growth, 3 years (yearly) | -1.9% | 20.7% |
| Profit growth, 3 years (yearly) | 70.7% | — |
| 1-year return | -27.5% | -12.4% |
| Revenue, last 12 months | ₹34 cr | ₹69 cr |
| Net profit, last 12 months | ₹0 cr | ₹-0 cr |
| Latest quarter | Jun 2026 | — |
| Quarter net profit | ₹0 cr | — |
| Quarter profit vs a year earlier | -95.4% | — |
| Promoter holding | 46.79% | — |
| Health check | Weak (2.6/10) | Weak (3.3/10) |
Common questions
Which earns a higher return on equity?
Biofil Chemicals & Pharmaceuticals Ltd. (13.8% against -0.4%).
Which carries more debt?
Onyx Biotec Ltd. has the higher debt-to-equity ratio (0.27 against 0.14).